CN Patent

CN116440089A — 含噁拉戈利的药物组合物及其制备方法

Assigned to Shanghai Desano Biopharmaceutical Co ltd · Expires 2023-07-18 · 3y expired

What this patent protects

本发明提供了一种含噁拉戈利的药物组合物及其制备方法。具体地，所述药物组合物包括：药物活性成分、填充剂、粘合剂、崩解剂和碱化剂；所述药物活性成分为噁拉戈利或其药学上可接受的盐；所述药物活性成分的BET比表面积在5m 2 /g–30m 2 /g；且所述药物组合物不包括碳酸钠。本发明的组合物具有优异的溶出特性，且避免了碳酸钠导致的胃肠道副作用。

USPTO Abstract

本发明提供了一种含噁拉戈利的药物组合物及其制备方法。具体地，所述药物组合物包括：药物活性成分、填充剂、粘合剂、崩解剂和碱化剂；所述药物活性成分为噁拉戈利或其药学上可接受的盐；所述药物活性成分的BET比表面积在5m 2 /g–30m 2 /g；且所述药物组合物不包括碳酸钠。本发明的组合物具有优异的溶出特性，且避免了碳酸钠导致的胃肠道副作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN116440089A
Jurisdiction
CN
Classification
—
Expires
2023-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Desano Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.